Walleye Capital LLC Invitae Corp Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.71 - $3.61 $67,032 - $141,512
39,200 New
39,200 $72,000
Q4 2019

Feb 14, 2020
SELL
$15.02 - $20.57 $102,136 - $139,876
-6,800 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$18.85 - $27.5 $331,760 - $484,000
-17,600 Reduced 72.13%
6,800 $131,000
Q2 2019

Aug 14, 2019
BUY
$17.37 - $26.27 $423,828 - $640,988
24,400 New
24,400 $573,000

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email